Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

MANDOL

CEFAMANDOLE NAFATE

Standard Dose
EQ 2GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview MANDOL is listed in Drugs@FDA under application 062560 (ANDA).

Marketing status: Discontinued Active ingredient CEFAMANDOLE NAFATE Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor LILLY Submission history Latest submission status date: 2007-12-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview MANDOL is listed in Drugs@FDA under application 062560 (ANDA). Marketing status: Discontinued Active ingredient CEFAMANDOLE NAFATE Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor LILLY Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.